#Hypolipidemic drugs Market Growth | Explore Tumblr Posts and Blogs

aartichede08 · 2 years

Text

Spirulina Market Demand, Industry Trends, Business Opportunities, And Forecast 2028

Spirulina is a multicellular, filamentous blue-green microalgae that naturally grows in warm regions in the alkaline waters of lakes, ponds and rivers. These microalgae is harvested and processed easily and have significantly high macro- and micronutrient contents. The increasing consumer awareness on health and wellness and their growing interest to adopt spirulina as a natural food color instead of synthetic colors is fueling the market growth. It appears guarantee as a malignant growth precaution operator and in the treatment of tumors. Spirulina appears to have widespread cardiovascular benefits, including improvement of blood lipid profiles, atherosclerosis aversion and hypertension control. Moreover, Spirulina appears to have extensive potential for development, especially as a small-scale crop for nutritional enhancement, livelihood development and environmental mitigation. In particular, the production and use of spirulina has major advantages like its production occupies in small environmental footprint, with considerable efficiencies in terms of water use, land occupation compared to traditional terrestrial crops. Also has the potential for integration with rural organic waste treatment processes to improve both environmental conditions and improve energy transfer efficiencies.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10969-spirulina-market-report

SPIRULINA MARKET REPORT OUTLOOK

The rising awareness among the population regarding health benefits of spirulina and wide application is the major factor propelling the growth of the spirulina market. Spirulina is gaining popularity due to several benefits associated includes high anti-oxidant, hypolipidemic, beta-carotene, and anti-inflammatory properties. The growing application in cosmetics and pharmaceutical industries is further expected to drive tremendous growth to this market during the forecast period. Further, the use of spirulina as protein supplement has gained considerable popularity in the human health food industry and in many developing countries, where there is prevalence of malnutrition which is fueling the market growth.

COVID 19 IMPACT ON SPIRULINA MARKET REPORT

The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Spirulina market. In addition, complete analysis of changes on the Spirulina expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 impact on spirulina market was moderate as Spirulina is extremely rich in vitamin C and minerals these products were recommended in pandemic for strengthening immunity at great level. Production and supply chain disruption however affected the market growth for few months in pandemic.

SPIRULINA MARKET SEGMENTAL OVERVIEW

The Spirulina market is segmented based on by type, by drug formulation, by application and geography.

SPIRULINA MARKET BY TYPE

The Spirulina are available in market according to different types like arthrospira platensis, arthrospira maxima.

The Arthrospira Platensis type was the major contributor in the global spirulina market growth owing to different factors such as surge in healthcare awareness and incorporation of spirulina in diets as super food globally. Spirulina Platensis gives enormous and incredible medical benefits to malnourished children, particularly under the age of five. Spirulina shows strong invulnerable animating impacts, shows antiviral movement against an assortment of hurtful infections. It is generally utilized as a Nutraceuticals nourishment supplement around the world which further fuels the market growth.

SPIRULINA MARKET BY DRUG FORMULATION

Depending on drug formulation Spirulina is accessible in powder, tablet & capsule, liquid, granule & gelling agent.

Powder segment holds a dominant position in drug formulation due to ease of application as compared to liquid forms. The spirulina powder market is expected to gain pace owing to government support encouraging production. Further, manufacturers are introducing new and exclusive products that attract consumers which in turn are likely to remain indispensable to the growth of the spirulina powder sector. The consumption and production of spirulina powder is increasing rapidly. Furthermore, tablet and capsule is expected to be the second largest segment during the forecast period.

SPIRULINA MARKET BY APPLICATION

Spirulina market finds its major application in nutraceuticals, cosmetic & personal care, food & beverages, animal feed, bio-fuel

Nutraceuticals application accounts the significant market share owing to rise in concern regarding health and nutrition and preference for natural organic alternative to traditional pharmaceutical products. Spirulina acts as food supplement with low or negligible side effects. One such Nutraceuticals is blue green algae, spirulina which is been used as part of human diet. The highly diverse nutritive nature of spirulina in Nutraceuticals provided with antioxidant and protective health benefits have been utilized in various health related problems. Furthermore, in cosmetic & personal care application spirulina has its major used in cosmetic formulators to promote healthy sunscreen protection, to treat skin pigmentation disorders and to heal wounds. Most of commercial cosmetics includes large range of spirulina properties, including antioxidant, revitalizing, demineralizing, moisturizing, protecting alongside cleansing and shining action, hydration, acts skin barrier function and oil control both for hair and for skin.

SPIRULINA MARKET BY GEOGRAPHY

Geographically the global Spirulina market is studied for the following region North America, Europe, Asia Pacific and LAMEA

North America is the leading market in the global spirulina market owing to increasing demand naturally derived food coloring agents in the regions. On the other hand Asia Pacific is anticipated to grow at the highest CAGR during the forecast period owing to robust economic growth in food industry as it offers lucrative opportunities to market players for launch innovative products. Furthermore rising urbanization and increasing middle class population is further fueling the regional growth. Also, increasing demand for spirulina powder among vegetarian consumer is another key factor driving the region growth in global spirulina market. Moreover, rapid growing aquaculture and extensive consumption of spirulina in aquatic farming and hatchery is expected to boost the spirulina market.

SPIRULINA MARKET KEY PLAYER

The major players in Spirulina market are Cyanotech Corporation, DIC Corporation, Chr. Hansen Holding A/S, Dongtai City Spirulina Bio-engineering Co., Ltd., Algenol Biofuels Inc., Prolgae, Sensient Technologies Corporation, Parry Neutraceuticals, DDW Inc., Naturex S.A., Algatec., Fuqing King Dnarmsa Spirulina Co., Ltd., GNC Holdings, Inc. , GNT Holding B.V. and Now Health Group Inc. among others.

SPIRULINA MARKET RECENT DEVELOPMENT

October 2020: Lubrizol life science had launched advanced, natural nutraceuticals solution to support mental agility. The product name Astagile microcapsules, new sustainable, organic-certified, astaxanthin (Haematococcus pluvialis), microencapsulated with spirulina. The two ingredients have been uniquely combined in a patent-pending product designed to promote mental agility and support healthy ageing for young and senior adults.

June 2020: DIC had launched small-volume (100 grams) bottled liquid version of Linablue natural blue food coloring. The natural plan derived pigment extracted from DIC Spirulina, Linablue continues to attract global attention and is used widely not only by overseas food product manufacturers concerned about food safety, but also by prominent domestic manufacturers, including the producer of a famous soda-flavored frozen confectionery.

Buy now Spirulina Market Report https://www.axiommrc.com/buy_now/10969-spirulina-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: [email protected]

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter: https://twitter.com/AxiommrcCom

#Research #market #reports #marketing #business #marketresearch #marketingstrategy

0 notes

precisemarketreportsandinsights · 7 years

Text

Hypolipidemic drugs Market Share And Analysis Report 2017 By Radiant Insights,Inc

This report splits Hypolipidemic drugs by Product Cholic acid regulator, by Product HMG-CoA reductase inhibitors, by Product Adenylate cyclase inhibitors, by Product Nicotinic acid drugs, by Product Others. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Hypolipidemic drugs industry.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-hypolipidemic-drugs-detailed-analysis-report-2017-2022

This report focus Global market, it covers details players regions product type and other details as following:

Major Companies

• ABBOTT LABORATORIES LIMITED

• Apotex Fermentation Inc.

• BIOCON LIMITED IN Bangalore

• Cadila Healthcare Limited

• Chunghwa Chem Syn& Biotech Co., Ltd

• CONCORD BIOTECH LIMITED Ahmedabad

• Croda Europe Limited Leek

• DAIICHI SANKYO CO., LTD. JP

• Dr. Reddy's Laboratories Ltd

• DSM Sinochem Pharma India

• HIKAL LIMITED Bangalore

• IPCA Laboratories Limited

• Lek Pharmaceuticals d.d.

• LUPIN LIMITED

• Merck Sharp & Dohme B.V.

• Moehs Iberica S.L. ES

• MYLAN LABORATORIES LIMITED

• Nexchem Pharmaceutical Co., Ltd. CN

• OLON S.P.A. IT Rodano

• Pfizer Inc.

• Recordati S.p.A. IT Milano

• SUN PHARMACEUTICAL LIMITED Mumbai

• TEVA PHARMACEUTICAL Petach Tikva

• Zhejiang Jiangbei Pharma Co. Ltd CN

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-hypolipidemic-drugs-detailed-analysis-report-2017-2022/request-sample

Main Regions

• United States

• Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Russia

• Netherland

• Poland

• Others

• China

• Japan

• India

• Southeast Asia

• Others

Main Product Type

Hypolipidemic drugs Market, by Product Cholic acid regulator

• ChoIestyramine

• CoIestipol

• Divistyramine

Hypolipidemic drugs Market, by Product HMG-CoA reductase inhibitors

• Simvastatin

• Lovastatin

• Pravastatin

• Atorvastatin

• Fluvastatin

Hypolipidemic drugs Market, by Product Adenylate cyclase inhibitors

• Clofibrate

• Fenofibrate

• Lifibrate

• Etofylline Clofibrate

• Gfibrozil

• Bezafibrate

• Simfibrate

Hypolipidemic drugs Market, by Product Nicotinic acid drugs

• Nicotinic Acid

• Lnositol Hexanicotinate

• Acipimox

Hypolipidemic drugs Market, by Product Others

• Omega-3

• Pantethine

• Probucol

• Elastase

Main Applications

• Hospital

• Pharmacy

• Clinic

• Cardiovasology

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100,

Suite 3036, San Francisco,

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: [email protected]

#Hypolipidemic drugs Market Share #Hypolipidemic drugs Market Analysis #Hypolipidemic drugs Market Growth #Hypolipidemic drugs Market Size

0 notes

pigmentation21 · 3 years

Text

Berberis vulgaris mother tincture vedas Cure

Berberis vulgaris mother tincture

Homeopathic medicine common barberry Mother Tincture is indicated in renal calculi (also referred to as a kidney stone or nephrolith). common barberry Mother Tincture is employed to dissolve and take away kidney stones. It gives relief in acute symptoms of kidney stones. daru haldi Table of Contents [hide] 1 common barberry Remedy is given just in case 2 ACTIVE INGREDIENT 3 What are the renal calculi? 4 Symptoms of urinary calculus 5 Complications of kidney stones 6 common barberry Mother Tincture Uses 7 Benefits of common barberry Mother Tincture 8 common barberry Mother Tincture Dosage 8.1 common barberry Mother Tincture Warnings Berberis Vulgaris may be a shrub found in Europe and North Asia and naturalized in North America. the main constituents of common barberry are isoquinoline alkaloids, principally berberine, occurring at a degree up to 4.5%. Other major alkaloids include oxyacanthine (0.04%), berbamine (0.6–1.2%), columbamine (0.3%), jatrorrhizine (0.4%) and magnoflorine (2.1%). Berberis Vulgaris has strong astringent and healing properties. it's a robust affinity with the urinary and digestive systems and is employed mainly within the treatment of kidney disorders. Berberis Vulgaris Remedy is given just in case Dark yellow Urine with a reddish, bran-like sediment Infection within the Kidney with tenderness and pain within the kidney area Kidney stones with severe, sharp, neuralgic, or colicky pain radiating from the kidneys to the bladder and down the legs Symptoms better when in rest, lying on the painful side Symptoms are worse by standing or movement. ACTIVE INGREDIENT Berberis vulgaris 1X INACTIVE INGREDIENTS Ethyl alcohol, Water PURPOSE Relieves pain thanks to kidney stones What are the renal calculi? Renal calculi or urinary calculus may be a condition during which a solid piece of fabric forms within the kidney. it's going to be as small as a grain of sand or as large as a pearl. A small urinary calculus generally passes through the tract on its own, causing little or no pain. a bigger urinary calculus may grind to a halt along the way. A urinary calculus that gets stuck can block your flow of urine, causing severe pain or bleeding. Symptoms of urinary calculus Blood in urine burning feeling on urinating Extreme pain in back or side that doesn't get away Fever and chills Urine that smells bad or looks cloudy Vomiting Complications of kidney stones If kidney stones aren't treated, they will cause: Hematuria, or blood within the urine Severe pain UTIs, including kidney infections Loss of kidney function A urinary calculus is diagnosed with urine, blood, and imaging tests. Treatment for kidney stones usually depends on their size, location, and what they're made from . Berberis Vulgaris Mother Tincture Uses Berberis Vulgaris may be a homeopathic medicine for the treatment of renal calculi. There are many other medicines available and therefore the selection of drugs for a specific case depends on symptoms presented by the patient. Kidney disorders Cystitis Lower-back pain Gallbladder problems Joint pain Benefits of common barberry Mother Tincture Relieves pain thanks to kidney stones Helps in diarrhea and constipation related to renal calculi Reduces bubbling sensation and stitching pain all around body and leg Berberis Vulgaris Mother Tincture Dosage Adult or child Five drops in 3 teaspoons of water, leaving a niche of half-hour from any food. Repeat every 2 hours until symptoms subside and three times daily for 3 days thereafter. Berberis Vulgaris Mother Tincture Warnings Consult your doctor if symptoms persist or worsen. If pregnant or breast-feeding ask a health care provider before use. Keep out of reach of youngsters . just in case of overdose, get medical help. Do you know mother tinctures are proven to be one among the foremost effective and fast-acting sorts of homeopathic medications? In India itself, quite 100 million people rely heavily on homeopathy for his or her medical requirements. Unlike conventional medicinal practice, homeopathy doesn't aim at treating the symptoms of an ailment. Rather, it focuses on getting to the basis of the matter and ensuring the entire well-being of a private . In recent years, enough evidence has been collected in support of homeopathy being effective in treating chronic skin diseases. Psoriasis is one such disease of the skin , mediated by the body’s system , which may be effectively treated with the utilization of common barberry mother tincture. EVERYTHING you ought to realize common barberry MOTHER TINCTURE ETYMOLOGY berberis vulgaris mother tincture Source: gobotany.nativeplanttrust.org Berberis Vulgaris may be a fruit-bearing plant used for a spread of medicinal purposes since past . common barberry fruits are mainly found in Iran but are native to other regions of the planet like Europe, Asia, Africa, North America also as South America. Not only fruits but also other parts of common barberry like its roots and leaves are used for the manufacture of traditional homeopathic medicine like the berberis mother tincture. WHAT ARE MOTHER TINCTURES IN HOMEOPATHY? Mother tinctures are herbal solutions made up of 100% natural extracts. The natural extracts might include natural minerals, plant parts, or maybe animals. Mother tinctures contain small amounts of alcohol and hence are easily absorbed by the physical body . they will be wont to address several medical issues like obesity, dandruff, high vital sign , skin problems, and baldness among many others. they're made with rock bottom possible potencies in homeopathic medication and thus are safe to use. PROPERTIES OF common barberry MOTHER TINCTURE The properties discovered in common barberry mother tincture are as follows: Antiedema Antihypersensitive Antihyperglycemic Hypolipidemic Antioxidant Anticholinergic Anticancer Antipyretic Antihistaminic Antimicrobial Hypnotic WHY common barberry is employed within the TREATMENT OF PSORIASIS? Psoriasis may be a chronic disease of the skin mediated by the autoimmune system. during this disease the life cycle of the skin accelerates , thereby forming layers of dead skin appearing like scales on the body. The skin gets flared up thanks to the extraordinary rapid cell growth with the formation of bumps and pustules. Psoriasis might appear to be only a disease of the skin but there's a high possibility that it’ll affect other parts of the body well. The underlying reason behind it's the body’s system acting against itself. Psoriasis are often caused thanks to numerous reasons, namely, Allergies Infections Stress Drug abuse Genetic factors Other illnesses Trauma experienced by the skin berberis vulgaris mother tincture Source: 1mg.com Berberis vulgaris mother tincture has antioxidant and anti inflammatory properties as mentioned below. thanks to this, it prevents the formation of poisons in faecal matter within the bowels. In homeopathic medicinal practice, its antimicrobial properties are beneficial within the treatment of urinary system-associated issues like urolithiasis also as tract infections. Such sorts of infections are a serious cause behind inducing psoriasis within the body. Therefore, berberis mother tincture are often used as a remedy for the treatment of psoriasis. The berberis mother tincture is claimed to be useful in reducing the synthesis of 5-lipoxygenase. This decreases inflammation and acts as an antioxidant. GENERAL BENEFITS OF BERBERIS MOTHER TINCTURE Berberis vulgaris mother tincture is primarily used for preventing renal conditions. Its general benefits include: It is beneficial within the treatment of kidney stones and also alleviates the severe abdominal pains related to it Berberis vulgaris tincture also helps in curing chronic cases of constipation and diarrhea It is helpful within the treatment of atrophic arthritis . The aches within the legs usually begin from the rear It is anti-inflammatory and thus helps relieve inflammation and gallbladder pain Berberis Vulgaris mother tincture acts as a natural pain reliever and it helps alleviate any pains related to the renal calculi It is also useful in skin-related ailments which include warts, pustules. These could also be amid itching of the skin. SIDE EFFECTS OF common barberry MOTHER TINCTURE berberis vulgaris mother tincture Source: en.wikipedia.org In general, common barberry mother tincture is manufactured employing a completely natural homeopathic formulation. Therefore there are not any side effects related to it as long because it is employed consistent with the prescribed dosage by the doctor. In case of overdosage, there are often multiple fatal consequences like: Symptoms of food poisoning like nausea, vomiting, and diarrhea Dizziness Fainting Low vital sign Decreased pulse Decreased breathing Hypersensitivity RECOMMENDED DOSAGE OF BERBERIS MOTHER TINCTURE The dosage of mother tinctures depends upon multiple factors. The severity of the condition to be treated is one among them. within the case of common barberry mother tincture, the doctor generally recommends 10 to fifteen drops of the tincture mixed in half a cup of water. it's to be taken 3 times each day preferably for visible results. MARKET PRICE OF common barberry MOTHER TINCTURE The price of this mother tincture varies from brand to brand. they are available in several sizes. common barberry mother tincture 100ml price usually ranges from 150/- INR to 250/- INR. SAFETY WARNINGS associated with USE OF BERBERIS MOTHER TINCTURE Use of common barberry mother tincture is totally safe when taken in appropriate quantities. a number of the security warnings that are related to it are: Pregnant and lactating women should consult the doctor before consuming berberis mother tincture Symptoms of poisoning by common barberry mother tincture include lack of energy, diarrhea along side vomiting, daze, stupor, and inflammation of kidneys A doctor’s prescription is mandatory. It isn’t recommended to be used by children 27.5 mg/kg is taken into account to be the median lethal dosage for berberis mother tincture. CONCLUSION berberis vulgaris mother tincture The effects of a chronic skin condition like psoriasis harm the psychological and physical health of the individual affected by it. the utilization of individualized homeopathic treatment can incite positive responses from the patients. Therefore, the holistic approach that's a trademark of homeopathy could also be useful within the treatment of psoriasis. This being said, it's to be kept in mind that there isn’t much research when it involves the security of homeopathy. The Food and Drug Administration (FDA) plays no part in monitoring the security and effectiveness of homeopathic medicines like common barberry mother tincture. Therefore one should only consider taking such homeopathic medicines under medical supervision.

0 notes

aleemtbrc · 4 years

Text

Cardiovascular Drugs Market Competitive Landscape and Regional Forecast Analysis 2022

TheBusinessResearchCompany published its Cardiovascular Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market. The report covers the cardiovascular drugs market’s segments- anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs).

Explore Complete Report https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Cardiovascular Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=smp

NOACs are gaining wider acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin. Anti-coagulants have long been used in prevention of thrombus formation in patients suffering with cardiovascular diseases. Use of NOACs makes it easier for patients to continue therapy post discharge as opposed to injections of Heparin and Warfarin which need medical assistance for administration. Some of the NOACs include Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, Xarelto (rivaroxaban) from Janssen, and Eliquis (apixaban) from Bristol-Myers Squibb.

Purchase Report (Individual License at USD 4000.00) At: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2134

Chapters from Table of Content:

Chapter 1. Executive Summary

Chapter 2. Report Structure

Chapter 3. Cardiovascular Drugs Market Characteristics

Chapter 4. Cardiovascular Drugs Market Product Analysis

Chapter 5. Cardiovascular Drugs Market Supply Chain

…….

Chapter 20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

Chapter 21. Market Background: Pharmaceutical Drugs Market

Chapter 22. Recommendations

Chapter 23. Appendix

Chapter 24. Copyright And Disclaimer

Few Points From List of Tables:

Table 1: Historic Market Growth, Value ($ Billion)

Table 2: Forecast Market Growth, Value ($ Billion)

Table 3: Global Cardiovascular Drugs Market, 2018, By Region, Value ($ Billion)

………..

Table 136: Global Cardiovascular Drugs Market In 2022- Growth Countries

Table 137: Global Cardiovascular Drugs Market In 2022- Growth Segments

Table 138: Global Cardiovascular Drugs Market In 2022- Growth Strategies

About Us:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

Follow our Blog: http://blog.tbrc.info/

#cardiovascular drugs market #global cardiovascular drugs market #anti-hypertensive drugs market

0 notes

viz-release-blog · 5 years

Text

Research and Markets: Research Report on Chinas Hypolipidemic Drug Market, 2012-2013

New Post has been published on https://vizrelease.com/press-release/1364967/

Research and Markets: Research Report on Chinas Hypolipidemic Drug Market, 2012-2013

According to surveys, the overall morbidity rate of dyslipidemia groups aged 18 and above is over 20% in China, and total patients are over 200 million nationwide. Blood lipid levels and morbidity rate of dyslipidemia of Chinese people are still lower than that in most developed countries. However, with the development of China’s economy, improvement in people’s living standards and changes in lifestyle, the morbidity rate of dyslipidemia gradually rises. Meanwhile, diabetes and metabolic syndrome closely related to dyslipidemia are also common in China.

According to market research, the market size of China’s hypolipidemic drugs exceeded CNY 12 billion in 2011, with an annual growth rate of over 15 %.

At present, blood lipid controlling drugs in the Chinese market are mainly divided into five categories: statins, fibrates, nicotinic acids, resins and cholesterol absorption inhibitors, also including some other drugs. Statins and fibrates occupy the largest market share in the Chinese market, and applications of other drugs are relatively a few. In terms of the market share of major varieties, the total market share of the top 5 hypolipidemic drug varieties in China was over 80% in 2009. Among them, the top 4 products all were statins (respectively: Atorvastatin, Simvastatin, Pravastatin and Fluvastatin), which occupied nearly 80% of the market share. In 2011, the market share of the top 5 varieties in China’s hypolipidemic market was 82.64%. Among them, the top 4 products were still statins (respectively: Atorvastatin, Simvastatin, Pravastatin and Fluvastatin), which accounted for 78% of the share. It is obvious that statin products are main forces in hyperlipidemia treatment drug market of China. Statins are always in leading positions in China’s hypolipidemic drug market. Because of excellent effects, little side effects and other multiple effects including lowering overall mortality rate, statin drugs are major drugs in the joint lipid-lowering program, thus occupying a most advantageous position clinically.

The overall performance of China’s hypolipidemic drugs in the drug market is better than that of the entire drug and cardiovascular system drug markets, showing a strong growth momentum. The expansion speed of hypolipidemic drug market is evidently higher than that of the cardiovascular drug market, and the proportion in cardiovascular system drugs gradually rises.

More following information can be acquired through this report:

– Status Quo of China’s Hypolipidemic Drug Market

– Status Quo of China’s Statin Drug Market

– Market Size of Major Varieties of China’s Hypolipidemic Drugs

– Competition in China’s Hypolipidemic Drug Market

– Market Prices of Major Hypolipidemic Drugs in China

– Prediction on Development of China’s Hypolipidemic Drugs

Following people are recommended to buy this report:

– Pharmaceutical Enterprises

– Pharmaceutical Trade Enterprises

– Hospitals

– Investors/Research Institutions Focusing on China’s Pharmaceutical industry

Chapter ONE: Clinical Application Status and Classification of Hypolipidemic Drugs

Chapter TWO: Analysis on Market Size of China’s Hypolipidemic Drugs, 2011-2012

Chapter THREE: Competition in China’s Hypolipidemic Drug Market, 2011-2012

Chapter FOUR: Analysis on Market Competition in Major Varieties of China’s Hypolipidemic Drugs

Chapter FIVE: RandD of Hypolipidemic Drugs, 2011-2012

Chapter SIX: Prediction on China’s Hypolipidemic Drug Market, 2013-2017

0 notes

srikanthgtbrc-blog · 5 years

Text

Global Hypolipidemics Market Overview And Top Key Players In 2019

The Business Research Company’s Hypolipidemics Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. Ratios of market size and growth to related markets, GDP proportions, and expenditure per capita for the market is detailed in the report. Data and analysis throughout the report is sourced using end notes.

Browse Hypolipidemics Global Market Report 2019

https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report

The hypolipidemics market is a segment of the pharmaceuticals market. The report will answer questions such as where the largest and fastest growing market is, how the market relates to the overall economy, demography and other similar markets, and what forces will shape the market going forward.The hypolipidemic drugs market consists of sales of hypolipidemic drugs and related services. This industry includes establishments that produce hypolipidemic drugs or agents that lower lipid and lipoproteins levels in the blood. These drugs can be used to prevent cardiovascular diseases and atherosclerosis in Hyperlipidemia patients. Some of the major hypolipidemic drugs include fibric acid derivatives, bile acid binding resins, nicotinamides, and cholesterol absorption inhibitors.

Place A Sample Request Of This Report At:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2435&type=smp

List Of Tables

Table 1: Global Historic Market Growth, 2014-2018, $ Billion

Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Table 3: Global Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 4: Global Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 5: Global Hypolipidemic Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 6: Global Hypolipidemic Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 7: Asia-Pacific, Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 8: Asia-Pacific, Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 9: China, Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 10: China, Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

View More Press Releases:

https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. The company has specialist consultants in different industries including manufacturing, healthcare, financial services and technology. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company

https://www.thebusinessresearchcompany.com

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

#hypolipidemics market

0 notes

theshadowytastemakerstuden-blog1 · 6 years

Text

Global Fatty Liver Disease Drugs Market Competitive Analysis of Top Players in Market

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Fatty Liver Disease Market on the basis of Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty Liver Disease or NAFLD), By Alcoholic Fatty Liver Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis), By Non Alcoholic Fatty Liver Stages (Non Alcoholic Steatosis, Non Alcoholic Steatohepatitis or NASH), By Alcoholic Liver Disease Drug (Opiod Antagonist, Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte colony stimulating factor), By Non Alcoholic Fatty Liver Drug (Antioxidants Thiazolidinedione, Biguanides, Lipid Lowering agents, FXR receptor agonist, Elafibranoer), By Region (North America, Europe, Asia Pacific and ROW) and By Country (U.S., Canada , U.K., France, Germany, China, Japan, India, Brazil, South Africa and Saudi Arabia).

Fill the form to get Exclusive Sample at: https://www.researchmoz.us/enquiry.php?type=S&repid=1256620

Over the recent years, the global fatty liver disease incidence has been growing rapidly with increase in prevalence of obesity, type II diabetes along with rising consumption of alcohol. Globally, the growth in the fatty liver disease market is driven by rising awareness among people by government organizations and private companies, heavy investments by pharmaceutical companies for the development of drugs along with launch of drugs for NASH in the forecasted period.

According to Azoth Analytics research report, the report Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) – By ALD Stages (Alcoholic Steatosis ,Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH) analyses the Global Fatty Liver Disease Market, Analysis By Type (Alcoholic Fatty Liver Disease or ALD), Non Alcoholic Fatty Liver Disease or NAFLD), By Alcoholic Fatty Liver Stages (Alcoholic Steatosis, Alcoholic Steatohepatitis or ASH), By Non Alcoholic Fatty Liver Stages (Non Alcoholic Steatosis, Non Alcoholic Steatohepatitis or NASH), By Alcoholic Liver Disease Drug (Opiod Antagonist, Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte colony stimulating factor) and By Non Alcoholic Fatty Liver Drug (Antioxidants Thiazolidinedione, Biguanides, Lipid Lowering agents, FXR receptor agonist, Elafibranoer). The global market is projected to display a robust growth represented by a CAGR of 22.67% during 2017 2022, chiefly driven by rising prevalence of obesity, diabetes and hypertension, rising clinical trials in Asian countries, heavy investments by government of different countries in their health care sector, rising research in developing the different health care machines and methodology for the detection of alcohol and non-alcohol steatosis at its early stage.

Read Overview of Report @ https://www.researchmoz.us/global-fatty-liver-disease-drugs-market-by-type-ald-nafld-by-stages-of-ald-and-nafld-by-region-by-country-opportunities-and-forecast-2017-2022-by-ald-stages-alcoholic-steatosis-alcoholic-steatohepatitis-by-nafld-stages-steatosis-nash-report.html

The report titled, Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) – By ALD Stages (Alcoholic Steatosis ,Alcoholic Steatohepatitis), By NAFLD Stages (Steatosis, NASH) has covered and analysed the potential of Global Fatty Liver Disease Market, NASH and NAFLD markets and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global fatty liver disease market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022) Fatty Liver Disease market Breakdown By NAFLD Stages (2012-2022): (Steatosis , NASH) Breakdown By ALD Stages (2012-2022): (Steatosis, Alcohol Hepatitis) Breakdown by ALD Drugs (2012-2022): (Opioid Antagonist ,Glucocorticoid, Pentoxifyline, Antioxidants, Granulocyte colony stimulating factor) Breakdown By NAFLD Drug (2012-2022): (Antioxidants Thiazolidinedione, Biguanides, Hypolipidemic Agents, FXR receptor agonist, Elafibranoer)

Regional Markets North America, Europe, APAC, ROW (Actual Period: 2012-2016 Forecast Period: 2017-2022) Fatty Liver Disease market Fatty Liver Disease market By Type (ALD, NAFLD) Breakdown by ALD Drugs (2012-2022) Breakdown By NAFLD Drug (2012-2022)

Make An Enquiry@ https://www.researchmoz.us/enquiry.php?type=E&repid=1256620

Country Analysis – UK, Germany, France, India, China, Japan, Brazil, Saudi Arabia, South Africa, U.S. and Canada (Actual Period: 2012-2016, Forecast Period: 2017-2022) Fatty Liver Disease market Fatty Liver Disease market By Type (ALD, NAFLD)

Other Report Highlights Market Dynamics Trends, Drivers, Challenges Policy and Regulation Company Analysis Pfizer, Gilead Sciences ,Astra Zenca, Immuron, Novartis,Takeda, Allergan , Intercept Pharmaceuticals, Conatus

Customization of the Report The report could be customized according to the clients specific research requirements. No additional cost will be required to pay for limited additional research.

About ResearchMoz ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact: ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Website: https://www.researchmoz.us Email: [email protected] Blog: https://researchknowledgeresource.blogspot.com/ Follow us on LinkedIn @ http://bit.ly/1TBmnVG

0 notes

jakehglover · 6 years

Text

What Are the Health Benefits of Yams?

By Dr. Mercola

Yams are one of the most delicious vegetables you can eat, but you may not be aware that, as a root vegetable that’s been around for eons, they also have a long history of use as an alternative medicine. Modern researchers are examining possible health benefits of wild yams that include relief from muscle cramps, rheumatoid arthritis and symptoms of menopause and diabetes prevention.

Over centuries, yams have gleaned a few other names, including China root, rheumatism root or colic root, which makes sense according to the potential aforementioned uses, but they’ve even been referred to as devil’s bones, which speculators have concluded must be because their roots are thin, long and tangled, giving them a skeletal look. The roots and rhizomes are what are typically used in natural medicine.

Many people believe differentiating the root vegetables yams and sweet potatoes is simply a matter of semantics, but the two are not even the same type of plant. Yams are part of the Dioscoreae family, which includes morning glories, while sweet potatoes belong to a genus called Convolvulaceae.1

Yams, from the Senegalese word “nyami,” means “to eat.” They have only one embryonic seed leaf, while sweet potatoes have two. Wild yams, unlike sweet potatoes, are rough, scaly and usually longer, but they’re more moist and less starchy in comparison.

The outer bark of the wild yam (Dioscorea rotundata) root is high in a compound called saponin, which research shows may help lessen inflammation and balance your gut flora. Not found in sweet potatoes, saponins include dioscin, diosgenin and dioscorin, the latter of which one study, among other things, says “They exhibit antioxidant, antihypertensive, immunomodulatory, lectin activities and can protect airway epithelial cells against dust mite allergen destruction.”2

Saponins have properties that combat inflammation and apparently help relax and otherwise treat a number of conditions involving your abdominal and pelvic muscles, as well as arthritic and rheumatic conditions, according to The Natural Path. In addition:

“Diosgenin was first identified in 1936 by scientists in Japan. This paved the way for the synthesis of progesterone and of such corticosteroid hormones such as cortisone. Diosgenin was also the starting point in the creation of the first contraceptive pill, despite the fact that there is no suggestion that the plant was used as a contraceptive in the past.

Over 200 million prescription drugs a year are sold that contain derivatives of this herb in them. Wild yam is collected in the wild and cultivated throughout Mexico to supply the pharmaceutical industry with diosgenin, this substance is used to treat sex hormone problems, to produce contraceptives, menopause, premenstrual syndrome, sexual problems, high blood pressure, prostate hypertrophy, testicular deficiency, impotency, just to name a few.

From this herb the pharmaceutical industry also indirectly produces cortisones and hydrocortisones for Addison's disease, some allergies, bursitis, contact dermatitis, psoriases, rheumatoid arthritis, sciatica and is used in the treatment of brown recluse spider bites, insect stings etc.”3

Are the Compounds in Yams Health Beneficial or Not?

Traditional medicine acknowledges yams as containing compounds said to be particularly advantageous for such issues as menopause and premenstrual syndrome for women, and testicular and prostate problems in men. Diosgenin is also said to “influence” the production of several useful hormones, including estrogen and DHEA (dehydroepiandrosterone). Medical News Today4 mentions several possible health benefits from eating yams, including:

Rheumatoid arthritis relief

Blood sugar regulation

Relief of cramps and muscular pain

The U.S. Food and Drug Administration (FDA) has yet to acknowledge any benefits connected to the safety or effectiveness of wild yams.5 Multiple studies beg to differ, however:

The “Handbook of Herbs and Spices” identifies diosgenin as the main steroid contained in saponin that may suppress inflammation and proliferation and induce apoptosis in a variety of tumor cells.6

Saponin was reported in a Korean study as a “promising bioactive biomolecule with diverse important medicinal properties.”7 Another cited yam and its active constituent allantoin as having the potential to modulate oxidative stress, antioxidant activities and lipid profiles; improve kidney and liver function; promote the release of GLP-1; and improve the function of β-cells8, thereby maintaining insulin and glucose levels.9

A comprehensive review involving researchers from the U.S., Vietnam, Singapore, Australia and India noted the ability of diosgenin to “prevent carcinogenesis by acting as an antioxidant and anti-inflammatory agent, and its ability to induce apoptosis of cancer cells, suggests that it can be useful as an anticarcinogenic agent.”10

The diosgenin in yams (as well as fenugreek) was shown in another study to increase milk flow and make childbirth easier.11 Diosgenin has been noted as exerting antidiabetic effects as well as hypolipidemic, hypoglycemic, antioxidant, anti-inflammatory and antiproliferative (cancer cell-inhibiting) activities.12

What About the Health Benefits of Sweet Potatoes?

Apparently, food producers have given up on trying to sort out what’s a yam and what’s a sweet potato. In fact, the U.S. Department of Agriculture now requires labels on yams to also mention “sweet potatoes” to stop the confusion, even though they’re not technically the same.13 As a result, unless you specifically search for yams, usually found in international markets, you’ll probably end up with sweet potatoes.

Their flavors are remarkably similar, as is, arguably, their overall appearance. Adding to the confusion, there are many varieties of sweet potatoes, but more than 600 types of yams, 95 percent of them grown in Africa. The outsides can be brown, red, purple, yellow or white, with flesh colors ranging from white to yellow to orange.

So are there any health benefits associated with eating sweet potatoes? Even though they’re sweet enough to be thought of as dessert in some circles, they’re still highly nutritious. High in vitamins, they’re one of the best sources of vitamin A, associated with antiaging benefits, cancer prevention and the maintenance of good eyesight,14 as well as B5, B6, niacin, thiamin and riboflavin, plus carotenoids. According to Live Science:

“Sweet potatoes have more powerful nutritional benefits than yams do. Sweet potatoes and yams are both healthy foods, and they look similar. Sweet potatoes, however, have higher concentrations of most nutrients and more fiber.”15

Nutrition Data compares the attributes of the two veggies and reports that boiled or baked yams16 are very good sources of fiber, vitamin C, potassium and manganese, while “cooked” or baked sweet potatoes17 are good sources of fiber, vitamin B6 and potassium, and a “very good” source of vitamins A and C and manganese.

It should be noted, though, that how they’re prepared impacts the nutritional potency of their vitamins and minerals. Frying them naturally compromises any health aspects, mostly due to reduced sugars, the cooking oil you use and high temperatures, which can raise the potential for acrylamide formation. The National Cancer Institute calls acrylamide a “potential human carcinogen.” It’s similar to what forms in tobacco smoke.18 Nutrition Facts asserts:

“Boiling may actually retain most of the antioxidant power of sweet potatoes, compared to roasting and steaming. If we compare baking to boiling microscopically, boiling helps thin out the cell walls and gelatinize the starch, which may enhance the bioavailability of nutrients. At the same time, the glycemic index of boiled sweet potatoes was found to be about half that of baking or roasting, so boiled sweet potatoes give us less of a blood sugar spike.

Make sure to keep the skin on, though. The peel of a sweet potato has nearly 10 times the antioxidant power as the flesh … However, the peel’s nutrition really takes a hit when baked, which wipes out over two-thirds of the antioxidants, whereas microwaving or boiling are comparatively much gentler. The same is true for the rest of the sweet potato. Baking can also cause an 80 percent drop in vitamin A levels, twice as much as boiling.”19

How Yam and Sweet Potato Intake Relates to Disease Prevention

Grown for around 10,000 years, sweet potatoes are native to Central and South America, while most yams are from Africa. Still, Natural Food Benefits20 notes how those and other nutrients relate to overall health benefits, to similar degrees, in both yams and sweet potatoes:

Heart — Vitamin B6 helps break down homocysteine, a substance that contributes to hardened blood vessels and arteries,21 while high potassium levels help lower your blood pressure and regulate your heartbeat.

Controlling blood sugar — They’re called “sweet” potatoes, but they have a low glycemic index, meaning they release sugars into your bloodstream slowly, which also helps maintain energy; manganese helps metabolize carbs and maintain blood sugar levels.

Immunity and inflammation fighting — Vitamins A (orange sweet potatoes contain more) and E support a healthy immune system, and extra antioxidants come in the purple variety, due to the anthocyanin content.22

Digestion and regularity — Fiber is plentiful in both yams and sweet potatoes, important because fiber helps maintain regularity and a healthy digestive system.23

Stress modulating — Magnesium in sweet potatoes provide de-stressing compounds to promote relaxation and a feeling of calm, plus it supports bone, muscle, blood, artery and nerve health.24

Skin and hair — Vitamin A also helps protect against sun damage,25 and C and E offer compounds to promote collagen growth for healthy, glowing skin.26

Cancer prevention — Orange sweet potatoes have high anticancer properties due to beta-carotenes, particularly ovarian cancer in postmenopausal women and breast cancer in premenopausal women, and the purple variety helps fight cancer cell growth.27

Medical News Today28 also suggests wild yam as a supplement may be “safe for most people,” but that large amounts could cause nausea, digestive issues, vomiting and headaches. Allergic reactions are also possible, it maintains, and not enough is known regarding whether young children or people who are pregnant, breast-feeding or have hormone-sensitive conditions, such as breast cancer or noncancerous uterine tumors, should use it.29

from HealthyLife via Jake Glover on Inoreader http://articles.mercola.com/sites/articles/archive/2018/07/23/yams-health-benefits.aspx

0 notes

pigmentation21 · 3 years

Text

Berberis vulgaris mother tincture

0 notes

thomasmartin16blr-blog · 7 years

Text

Worldwide and Europe Hypolipidemic drugs Market – Analysis and Outlook to 2022 – Reports Monitor

This report presents a comprehensive overview of the Hypolipidemic drugs market in Europe. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Hypolipidemic drugs industry.

This report focus Global and Europe market, it covers details players regions product type and other details as following:

To Browse Complete report visit @ https://www.reportsmonitor.com/global-and-europe-hypolipidemic-drugs-market-analysis-and-outlook-to-2022/ Key Players

ABBOTT LABORATORIES LIMITED Moehs Iberica S.L. ES Apotex Fermentation Inc. MYLAN LABORATORIES LIMITED BIOCON LIMITED IN Bangalore Nexchem Pharmaceutical Co., Ltd. CN Cadila Healthcare Limited OLON S.P.A. IT Rodano Chunghwa Chem Syn& Biotech Co., Ltd Pfizer Inc. CONCORD BIOTECH LIMITED Ahmedabad Recordati S.p.A. IT Milano Croda Europe Limited Leek SUN PHARMACEUTICAL LIMITED Mumbai DAIICHI SANKYO CO., LTD. JP TEVA PHARMACEUTICAL Petach Tikva Dr. Reddy�s Laboratories Ltd Zhejiang Jiangbei Pharma Co. Ltd CN DSM Sinochem Pharma India HIKAL LIMITED Bangalore IPCA Laboratories Limited Lek Pharmaceuticals d.d. LUPIN LIMITED Merck Sharp & Dohme B.V.

Key Regions Europe Germany United Kingdom France Italy Spain Russia Netherland Poland Others United States China Japan India Others

To Get Request Sample report visit @ https://www.reportsmonitor.com/request-sample/?post=259951

Key Product Type

by Product Cholic acid regulator ChoIestyramine, CoIestipol, Divistyramine

by Product HMG-CoA reductase inhibitors Simvastatin, Lovastatin, Pravastatin, Atorvastatin, Fluvastatin

by Product Adenylate cyclase inhibitors Clofibrate, Fenofibrate, Lifibrate, Etofylline Clofibrate, Gfibrozil

by Product Nicotinic acid drugs Nicotinic Acid, Lnositol Hexanicotinate, Acipimox

by Product Others Omega-3, Pantethine, Probucol, Elastase

Key Applications

Hospital Pharmacy Clinic Cardiovasology

About Us

Reports Monitor (ReportsMonitor.com) is a platform for companies looking to meet their market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. The prime focus is to get reliable data, Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.

Jay Matthews

Direct: +1 513 549-5911

Email: [email protected]

Website: http://www.reportsmonitor.com

0 notes

aleemtbrc · 5 years

Link

0 notes

aleemtbrc · 5 years

Text

Global Cardiovascular Drugs Market to Witness a Pronounce Growth During 2019-2022

TheBusinessResearchCompany published its Cardiovascular Drugs Global Market Report 2019 which provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market. The report covers the cardiovascular drugs market’s segments- anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs).

Explore Complete Report https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Cardiovascular Drugs Global Market Report 2019 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 50+ geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=smp

Get Discount On This Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=discount

Chapters from Table of Content:

Chapter 1. Executive Summary

Chapter 2. Report Structure

Chapter 3. Cardiovascular Drugs Market Characteristics

Chapter 4. Cardiovascular Drugs Market Product Analysis

Chapter 5. Cardiovascular Drugs Market Supply Chain

…….

Chapter 21. Market Background: Pharmaceutical Drugs Market

Chapter 22. Recommendations

Chapter 23. Appendix

Chapter 24. Copyright And Disclaimer

Few Points From List of Tables:

Table 1: Historic Market Growth, Value ($ Billion)

Table 2: Forecast Market Growth, Value ($ Billion)

Table 3: Global Cardiovascular Drugs Market, 2018, By Region, Value ($ Billion)

………..

Table 136: Global Cardiovascular Drugs Market In 2022- Growth Countries

Table 137: Global Cardiovascular Drugs Market In 2022- Growth Segments

Table 138: Global Cardiovascular Drugs Market In 2022- Growth Strategies

About Us:

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

#cardiovascular drugs market #global cardiovascular drugs market #anti-hypertensive drugs market #cardiovascular drugs market size

0 notes